PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180813 224437
20180812 153134
20180815 133138
20180815 171426
20180815 142325
20170731 011047
  • Biologics Electronic Reading Room (eFOIA)
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-09-02 By FDA
  • Drug Safety Oversight Board
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • DG Gel Card 125445, 125449, 125450 - 125457
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-09-02 By FDA
  • FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • FDA-TRACK: Prescription Drug User Fee Act Procedural Goals Summary
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • Over-The-Counter Monograph Drug User Fee Program (OMUFA)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • Meetings, Conferences, & Workshops | Drugs
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • Assessing Novel Efficacy Endpoints in Ophthalmologic Rare Disease Drug and Biologics Development - 09/17/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-02 By FDA
  • Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 18, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-02
  • Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 20, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-02
  • Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 12, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-02
  • Human medicines European public assessment report (EPAR): Ebilfumin, oseltamivir, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-02
  • Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 38, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-02
Предыдущие записи
Тема: Scaffold от Danny Cooper.